$1.02
7.77% day before yesterday
Nasdaq, Sep 06, 10:00 pm CET
ISIN
US0537342083
Symbol
AVGR

Avinger, Inc. Stock price

$1.02
-0.23 18.41% 1M
-2.68 72.43% 6M
-1.69 62.36% YTD
-5.64 84.69% 1Y
-265.98 99.62% 3Y
-340.98 99.70% 5Y
-1,619,998.98 100.00% 10Y
Nasdaq, Closing price Fri, Sep 06 2024
+0.07 7.77%
ISIN
US0537342083
Symbol
AVGR
Sector

Key metrics

Market capitalization $2.34m
Enterprise Value $-710.00k
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 0.05
EV/Sales (TTM) EV/Sales -0.10
P/S ratio (TTM) P/S ratio 0.31
P/B ratio (TTM) P/B ratio 0.25
Revenue growth (TTM) Revenue growth -9.20%
Revenue (TTM) Revenue $7.43m
EBIT (operating result TTM) EBIT $-17.86m
Free Cash Flow (TTM) Free Cash Flow $-15.23m
Cash position $8.81m
EPS (TTM) EPS $-13.44
P/S forward 0.33
EV/Sales forward negative
Short interest 3.39%
Show more

Is Avinger, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Avinger, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Avinger, Inc.:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Avinger, Inc.:

Buy
100%

Financial data from Avinger, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
7.43 7.43
9% 9%
100%
- Direct Costs 5.95 5.95
9% 9%
80%
1.48 1.48
45% 45%
20%
- Selling and Administrative Expenses 14 14
12% 12%
185%
- Research and Development Expense 4.16 4.16
9% 9%
56%
-16 -16
17% 17%
-221%
- Depreciation and Amortization 1.43 1.43
3% 3%
19%
EBIT (Operating Income) EBIT -18 -18
15% 15%
-240%
Net Profit -19 -19
13% 13%
-261%

In millions USD.

Don't miss a Thing! We will send you all news about Avinger, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Avinger, Inc. Stock News

Neutral
Accesswire
18 days ago
REDWOOD CITY, CA / ACCESSWIRE / August 20, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced full commercial launch of the Pantheris LV image-guided directional atherectomy system. With the initiation of full commercial launc...
Neutral
Seeking Alpha
29 days ago
Avinger, Inc. (AVGR) Q2 2024 Earnings Call Transcript
Neutral
Accesswire
about one month ago
Implements Lower Operating Cost Profile, Readying OCT-Guided Coronary Device for IDE Submission REDWOOD CITY, CA / ACCESSWIRE / August 8, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today reported results for the second...
More Avinger, Inc. News

Company Profile

Avinger, Inc. manufactures catheter devices used to treat vascular diseases. It designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease. Its products include Pantheris, Lightbox, Ocelot, Ocelot MVRX, Ocelot PIXL, Pantheris, Wildcat, Juicebox and Kittycat 2. The company offers its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger was founded by John B. Simpson and Himanshu N. Patel on March 8, 2007 and is headquartered in Redwood City, CA.

Head office United States
CEO Jeffrey Soinski
Employees 72
Founded 2007
Website www.avinger.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today